Study of ZG005 in Combination With Platinum-Based Chemotherapy in Participants With Advanced Biliary Tract Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Gemcitabine
Related studies linked through entity extraction aliases.
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
- Status
- RECRUITING
- Phase
- PHASE3
Utility of ctDNA in Early Switch of First-line mFOLFIRINOX in Metastatic Pancreatic Ductal Adenocarcinoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Compare QLS31905 and Chemotherapy With Placebo and Chemotherapy in Participants With Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE3
A Study Comparing BMS-986504 in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Gemcitabine and Carboplatin After Progression on Enfortumab Vedotin and Pembrolizumab in Advanced/Metastatic Urothelial Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma
- Status
- RECRUITING
- Phase
- PHASE2
PANORAMIX : Optimizing 1st-line NALIRIFOX and Exploring Microbiota's Role in 2nd Line Pancreatic Cancer Treatment
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal Cancer
- Status
- RECRUITING
- Phase
- PHASE1
ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Chemoablation for Low-Grade Bladder Cancer
- Status
- RECRUITING
- Phase
- PHASE2
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Compare Uliledlimab Combined With Sintilimab and Chemotherapy Versus Sintilimab Combined With Chemotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Oral Pooled Fecal Microbiotherapy (MaaT033) Concomitant to Cemiplimab Versus Best Investigator's Choice in Patients With Resistance to Treatment Due to Antibiotics Uptake With Advanced Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
- Status
- RECRUITING
- Phase
- PHASE3
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
- Status
- RECRUITING
- Phase
- PHASE3
Perioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/Cisplatin in Patients With Muscle-invasive Bladder Cancer (NIAGARA-2)
- Status
- RECRUITING
- Phase
- PHASE3
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE3